These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2656291)

  • 1. Endogenous megakaryocyte colonies from peripheral blood in precursor cell cultures of patients with myeloproliferative disorders.
    Battegay EJ; Thomssen C; Nissen C; Gudat F; Speck B
    Eur J Haematol; 1989 Apr; 42(4):321-6. PubMed ID: 2656291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
    Michiels JJ; Juvonen E
    Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin-3.
    Kobayashi S; Teramura M; Hoshino S; Motoji T; Oshimi K; Mizoguchi H
    Br J Haematol; 1993 Apr; 83(4):539-44. PubMed ID: 7686030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous megakaryocyte colony formation in myeloproliferative disorders is not neutralizable by antibodies against IL3, IL6 and GM-CSF.
    Li Y; Hetet G; Maurer AM; Chait Y; Dhermy D; Briere J
    Br J Haematol; 1994 Jul; 87(3):471-6. PubMed ID: 7993786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
    Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
    Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous megakaryocyte and erythroid colony formation from blood in essential thrombocythaemia.
    Florensa L; Besses C; Woessner S; Solé F; Acín P; Pedro C; Sans-Sabrafen J
    Leukemia; 1995 Feb; 9(2):271-3. PubMed ID: 7869763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonality assays and megakaryocyte culture techniques in essential thrombocythemia.
    Yan L; Elkassar N; Gardin C; Briere J
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():31-40. PubMed ID: 8951770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Megakaryocytopoiesis in polycythemia vera: characterization by megakaryocytic progenitors (CFU-Meg) in vitro and quantitation of marrow megakaryocytes.
    Kimura H; Ohkoshi T; Matsuda S; Uchida T; Kariyone S
    Acta Haematol; 1988; 79(1):1-6. PubMed ID: 3124455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic applications of haemopoietic progenitor culture techniques in polycythaemias and thrombocythaemias.
    Westwood NB; Pearson TC
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():95-103. PubMed ID: 8951779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders.
    Hibbin JA; Njoku OS; Matutes E; Lewis SM; Goldman JM
    Br J Haematol; 1984 Jul; 57(3):495-503. PubMed ID: 6743569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous megakaryocytic colony formation and thrombopoietin sensitivity of megakaryocytic progenitor cells are useful to distinguish between essential thrombocythemia and reactive thrombocytosis.
    Mi JQ; Blanc-Jouvan F; Wang J; Sotto MF; Cousin F; Castinel A; Chauvet M; Sotto JJ; Polack B; Mossuz P
    J Hematother Stem Cell Res; 2001 Jun; 10(3):405-9. PubMed ID: 11454315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of megakaryocyte colony formation in normal individuals and in primary thrombocythemia: studies using an optimal cloning system.
    Han ZC; Briere J; Abgrall JF; Sensebe L; Parent D; Guern G
    Exp Hematol; 1989 Jan; 17(1):46-52. PubMed ID: 2908860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with idiopathic myelofibrosis show increased CD34+ cell concentrations in peripheral blood compared to patients with polycythaemia vera and essential thrombocythaemia.
    Andréasson B; Swolin B; Kutti J
    Eur J Haematol; 2002 Apr; 68(4):189-93. PubMed ID: 12071933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polycythemia: primary or secondary? The differential diagnostic value of stem cell cultures].
    Küng C; Huxol H; Müller R; Speck B; Nissen C
    Schweiz Med Wochenschr; 1993 Jan; 123(3):53-6. PubMed ID: 8426948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous erythroid and megakaryocytic colony formation in serum-free, cytokine-free collagen gels.
    Dobo I; Pineau D; Zandecki M; Hunault M; Hermouet S
    J Hematother Stem Cell Res; 1999 Dec; 8(6):601-7. PubMed ID: 10645767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: diagnostic value and correlation to complications.
    Juvonen E; Ikkala E; Oksanen K; Ruutu T
    Br J Haematol; 1993 Feb; 83(2):192-7. PubMed ID: 8457466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cells from patients with polycythemia vera elaborate growth factors which contribute to endogenous erythroid and megakaryocyte colony formation.
    Ishii T; Zhao Y; Shi J; Sozer S; Hoffman R; Xu M
    Leukemia; 2007 Dec; 21(12):2433-41. PubMed ID: 17713553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
    Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
    Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous erythroid colony formation by peripheral blood mononuclear cells from patients with myelofibrosis and polycythemia vera.
    Lutton JD; Levere RD
    Acta Haematol; 1979; 62(2):94-9. PubMed ID: 119408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early and late hemopoietic precursor cells in patients with chronic myeloproliferative diseases.
    Gerasimova LP; Vakhrusheva MV; Miterev GY; Sokolova MA; Momotyuk KS; Thrkina AG; Khoroshko ND
    Bull Exp Biol Med; 2007 Aug; 144(2):181-4. PubMed ID: 18399275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.